참고문헌
- Bosari S, Lee AK, Delellis RA, et al (1992). Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol, 23, 755-61. https://doi.org/10.1016/0046-8177(92)90344-3
- Cavallaro U, Tenan M, Castelli V, et al (2001). Response of bovine endothelial cells to FGF-2 and VEGF is dependenton their site of origin: Relevance to the regulation of angiogenesis. J Cell Biochem, 82, 619-33. https://doi.org/10.1002/jcb.1190
- Conn EM, Botkjaer KA, Kupriyanova TA, et al (2009). Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Am J Pathol, 175, 1638-52. https://doi.org/10.2353/ajpath.2009.090384
- Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol, 146, 1029-39.
- Huang HY, Jiang ZF, Li QX, et al (2010). Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator. Cancer Invest, 28, 689-97. https://doi.org/10.3109/07357901003735642
-
Iseki K, Tat suata M, Uehara H, et al (1999). Inhibitor of angiogenesis as a mechanism for inhibitor by
$1\alpha$ -hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymet hane in Wistar rat. Int Cancer, 81, 730-3. https://doi.org/10.1002/(SICI)1097-0215(19990531)81:5<730::AID-IJC11>3.0.CO;2-Q - Isogai C, Laug WE, Shimada H, et al (2001). Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res, 61, 5587-94.
- Kang ZQ, Jiang B, Li P, Wang YJ (2003). Expression of urokinase-type plasminogen activator in non-small cell lung cancer. Academic J Second Military Medical University, 24, S4-5.
- Katoh Y, Katoh M (2006). Comparative integromics on VEGF family members. Int J Oncol, 28, 1585-9.
- Liu G, Zhang W, Jiang P, et al (2012). Role of nitric oxide and vascular endothelial growth factor in fluoride-induced goitrogenesis in rats. Environ Toxicol Pharmacol, 34, 209-17. https://doi.org/10.1016/j.etap.2012.04.003
- Mazar AP (2008). Urokinase plasminogen activator receptor choreographs multiple ligand interaetions: implieations for tumor progression and therapy. Clin Cancer Res, 14, 5649-55. https://doi.org/10.1158/1078-0432.CCR-07-4863
- Pengchong H, Tao H (2011). Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma. Eur J Gynaecol Oncol, 32, 660-4.
- Qin R, Sheng X, Wu JF, Wang DB (2005). Expression of urokinase-type plasminogen activator system and vascular endothelial growth factor in human gastric cancer and the relationship with tumor invasion and metastasis. World Chin J Digestol, 13, 706-10.
- Reuning U, Magdolen V, Hapke S, Schmitt M (2003). Molecular and functional interdependence ofthe urokinase-type plasminogen activatorsystem with integrins. Biol Chem, 384, 1119-31. https://doi.org/10.1515/BC.2003.125
- Schmitt M, Harbeck N, Brunner N, et al (2011). Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diadn, 11, 617-34. https://doi.org/10.1586/erm.11.47
- Schmitt M, Harbeck N, Thomssen C, et al (1997). Clinical impact of the plasminogen activation and target for therapy. Thromb Haemost, 78, 285-96.
- Viacava P, Gasperi M, Acerbi G, et al (2003). Microvasscular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas. Endocrinol Invest, 26, 23-8. https://doi.org/10.1007/BF03345118
- Xiao JP, Zhang L, Qi Y, Gong P (2007). Expression and Significance of uPA and VEGF in Breast Carcinoma. Chin J General Surgery, 16, 93-6.
- Yoshizawa K, Nozaki S, Kitahara H, et al (2011). Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors. Oncol Rep, 26, 1555-60.
- Zhang QX, Magovern CJ, Mack CA, et al (1997). Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res, 67, 147-54. https://doi.org/10.1006/jsre.1996.4983
- Zhang Y, Han J, Yang X, et al (2011). Pigment epithelium-derived factor inhibits angiogenesis and growth of gastric carcinoma by down-regulation of VEGF. Oncol Rep, 26, 681-6.
피인용 문헌
- Combination of FDG PET/CT and Contrast-Enhanced MSCT in Detecting Lymph Node Metastasis of Esophageal Cancer vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7719
- Synergistic effects of curcumin and bevacizumab on cell signaling pathways in hepatocellular carcinoma pp.1792-1082, 2014, https://doi.org/10.3892/ol.2014.2694
- VEGF-C and VEGF-D Expression and its Correlation with Lymph Node Metastasis in Esophageal Squamous Cell Cancer Tissue vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.271
- Role of +405C>G and +936C>T Polymorphisms of the Vascular Endothelial Growth Factor Gene and Risk of Esophageal Cancer in the Kashmiri Population vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.97
- Pathologic Response During Chemo-radiotherapy and Variation of Serum VEGF Levels Could Predict Effects of Chemo-Radiotherapy in Patients with Esophageal Cancer vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1111
- Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma vol.98, pp.9, 2019, https://doi.org/10.1097/MD.0000000000014717